| 2025-12-16 |
详情>>
内部人交易：
Schroeter Martin J等共交易5笔
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本22856.43万股
|
| 2025-11-05 |
详情>>
业绩披露：
2026年中报每股收益0.54美元,归母净利润1.24亿美元,同比去年增长487.50%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘后发布财报
|
| 2025-08-05 |
详情>>
业绩披露：
2026年一季报每股收益0.24美元,归母净利润5600.00万美元,同比去年增长409.09%
|
| 2025-06-16 |
股东大会：
将于2025-07-31召开股东大会
会议内容 ▼▲
- 1.Election of the three director nominees named herein for a one-year term
2.Approval, in an advisory, non-binding vote, of the compensation of our named executive officers
3.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026
4.Transaction of any other business properly presented at the meeting
|
| 2025-05-30 |
详情>>
业绩披露：
2025年年报每股收益1.09美元,归母净利润2.52亿美元,同比去年增长174.12%
|
| 2025-02-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.79美元,归母净利润1.83亿美元,同比去年增长162.03%
|
| 2024-11-07 |
详情>>
业绩披露：
2025年中报每股收益-0.14美元,归母净利润-3200万美元,同比去年增长88.69%
|
| 2024-08-07 |
详情>>
业绩披露：
2025年一季报每股收益0.05美元,归母净利润1100.00万美元,同比去年增长107.80%
|
| 2024-06-12 |
股东大会：
将于2024-07-25召开股东大会
会议内容 ▼▲
- 1.Election of the four Class III directors named herein for a three-year term
2.Approval, in an advisory, non-binding vote, of the compensation of our named executive officers
3.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2025
4.Transaction of any other business properly presented at the meeting
|
| 2024-05-30 |
详情>>
业绩披露：
2024年年报每股收益-1.48美元,归母净利润-3.4亿美元,同比去年增长75.25%
|
| 2024-02-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.29美元,归母净利润-2.95亿美元,同比去年增长53.69%
|
| 2023-11-08 |
详情>>
业绩披露：
2024年中报每股收益-1.24美元,归母净利润-2.83亿美元,同比去年增长46.70%
|
| 2023-06-14 |
股东大会：
将于2023-07-27召开股东大会
会议内容 ▼▲
- 1.Election of the three Class II directors named herein for a three-year term
2.Approval, in a non-binding vote, of the compensation of our named executive officers
3.Approval of the amendment and restatement of the Amended and Restated Kyndryl 2021 Long-Term Performance Plan
4.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2024
5.Transaction of any other business properly presented at the meeting
|
| 2023-06-14 |
股东大会：
将于2023-07-27召开股东大会
会议内容 ▼▲
- 1.Election of the three Class II directors named herein for a three-year term
2.Approval, in a non-binding vote, of the compensation of our named executive officers
3.Approval of the amendment and restatement of the Amended and Restated Kyndryl 2021 Long-Term Performance Plan
4.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2024
5.Transaction of any other business properly presented at the meeting
|
| 2022-06-14 |
股东大会：
将于2022-07-28召开股东大会
会议内容 ▼▲
- 1.Election of the three Class I directors named herein for a three-year term
2.Approval, in a non-binding vote, of the compensation of our named executive officers
3.Approval, in a non-binding vote, of the frequency of future advisory votes on executive compensation
4.Approval of the amendment and restatement of the Kyndryl 2021 Long-Term Performance Plan
5.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2023
6.Transaction of any other business properly presented at the meeting
|